US Blood Glucose Monitoring System Market Size & Share

1. The U.S. blood glucose monitoring system market is projected to grow from $6.82 billion in 2023 to $12.94 billion by 2030, at a CAGR of 9.6%. Key market drivers include:  Rising diabetes prevalence: According to CDC data, approximately 37.3 million people in the U.S. have diabetes (11.3% of population)  Growing adoption of continuous glucose monitoring (CGM) systems  Increasing product approvals and launches by major companies Market segments:  Device Types: oCGM systems (largest segment) oSelf-monitoring blood glucose systems Leading companies:  Dexcom, Inc. (market leader in CGM)  Abbott  Medtronic Recent developments:  In December 2022, Dexcom received FDA clearance for its G7 CGM system  In October 2022, Abbott launched the FreeStyle Libre 3 system  In March 2022, Dexcom received breakthrough device designation for CGM use in hospitals Key challenges include:  High device costs limiting adoption  Delays in product approvals compared to other markets  Complex regulatory requirements Report- Fortune Business Insights - U.S. Blood Glucose Monitoring System Market Statistics [2030] https://www.fortunebusinessinsights.com/u-s-blood-glucose-monitoring-system-market-107369